As a leading biopharmaceutical company, Pfizer is dedicated to the discovery and delivery of high value therapies across a variety of disease areas. It is our mission to bring innovative medicines to patients that significantly improve their lives, and our priority is to ensure patients have access to these medicines.
The Value and Evidence (V&E) team is responsible for ensuring patients have affordable, timely access to medicines and vaccines by advancing innovative value and evidence solutions to inform healthcare decision-making.
The V&E Senior Director, Hematology role will be primarily responsible for developing and implementing the integrated Value and Evidence Strategy (IVES) for TTI-622, covering multiple indications. The role will also be responsible for contributing to the evidence generation activities associated with our in-line hematology and biosimilar (BSM) assets.
The candidate will be responsible for serving as a senior V&E strategist for these programs, which includes oversight and development of timely and impactful evidence generation, and training and dissemination of technical deliverables that support their value globally.
The execution of this leadership position will be in close collaboration with Pfizer stakeholders including the VASL/VASTL, RWE CoE, and cross-functional teams such as Clinical, GPD, Statistics, US & Global Medical, and Field Medical among others.
The V&E Senior Director will function with a one-PHI mindset, promoting behaviors that exemplify Pfizer’s values (Courage, Excellence, Equity and Joy) within the team and will work in a closely aligned fashion with other PHI team members. This is an individual contributor role without direct reports; however, you will be responsible for helping the V&E Hematology & BSM team lead in mentoring other V&E scientists in developing their V&E competencies.
Independently lead and deliver senior-level strategic thinking from a Value & Evidence perspective in support of TTI-622 and, as appropriate, in-line hematology and BSM assets.
Be a strategic partner to the TTI-622 team (and as appropriate, in-line heme/BSM teams), V&E Team Lead and VAS leadership in high-level, cross-functional strategy meetings with Senior and Executive Leaders
Incorporate humanistic and economic endpoints into clinical trials across all phases of product development to build comprehensive trial-based evidence aligned with overall asset strategy and to ensure global reimbursement and access requirements. Provide strategic input into clinical trial designs (e.g., patient populations, comparators, endpoints) to enable successful negotiations, reimbursement, and appropriate patient access with global payer and regulatory decision makers.
Lead the coordination of input from local country/regional teams on evidence needs and ensure that the input is appropriately incorporated to develop and integrate the evidence strategy to support global market access needs at launch and through lifecycle.
Lead the design and execution of global health economics & outcomes research (HEOR) studies (e.g., network meta-analyses, non-interventional studies) from concept through publication.
Lead the timely development of launch deliverables including early global value dossiers, evidence blueprints, systematic literature reviews, early economic models, and innovative tools to successfully support reimbursement and access requirements in conjunction with the regions/countries.
Mentor other members of the team in their execution of HEOR studies and launch deliverables.
Prepare clear, relevant, and influential written reports and presentations for a variety of audiences and effectively present information to senior and executive management at Pfizer.
Represent Pfizer before appropriate scientific, medical, regulatory, payer, patient & other meetings, as appropriate.
Execute in a manner that is compliant, with integrity, and follows the appropriate SOPs and Engagement policies.
Master's Degree in public health, health economics or allied discipline
10+ years pharmaceutical industry, HEOR consulting, or HEOR academic roles or related experience including US healthcare experience from a HEOR capacity
Substantial technical knowledge and extensive experience in planning and executing on HEOR strategy (in particular real-world evidence, PROs and economic modelling)
Demonstrated ability to manage multiple projects involving complex processes, significant budget, competing deadlines and rapidly shifting priorities
Wide professional networks and established track record of working with external KOLs
Ability to influence key members of scientific and commercial teams, and across the alliance, constructively and strategically, with minimal conflicts
Excellent oral and written English communication skills
Strong collaborator and team-player
Demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact
PhD or similar advanced degree in health services research, public health, epidemiology or health economics, or psychometric research and 10+ years' experience in pharmaceutical industry, HEOR consulting, or HEOR academic roles or related experience.
Experience in Oncology from an HEOR perspective and in particular, hematology will be a plus
Technical and methodological aspects of RWE such as retrospective and prospective observational study design and implementation in US and other countries (real world evidence)
In depth understanding of pharmacoeconomics including advanced modelling techniques, health-related quality of life, other PRO measures and macroeconomics.
Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.
NON-STANDARD WORK SCHEDULE, TRAVEL OR ENVIRONMENT REQUIREMENTS
Travel may be required within the US and internationally. Tight deadlines and shifting priorities are characteristic of this role.
Other Job Details
Work Location Assignment:Flexible
Last Day to Apply: August 17, 2022
Pfizer requires all U.S. new hires to be fully vaccinated for COVID-19 prior to the first date of employment. As required by applicable law, Pfizer will consider requests for Reasonable Accommodations.
Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care provider’s name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.
EEO & Employment Eligibility
Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer.